There’s a moment that many women describe the same way: “I used to be able to lose five pounds in two weeks just by cutting out wine and walking more. Now I’m doing everything right and nothing is moving.” If that’s your experience, you’re not broken. You’re experiencing a well-documented metabolic shift — one that conventional weight loss advice was never designed to address.
Here’s what’s actually happening, and why the conversation has finally started to change.
Your Metabolism Is Not What It Was
Resting metabolic rate — the number of calories your body burns just to stay alive — is closely tied to muscle mass. Starting in your mid-30s, women lose muscle tissue at an accelerating rate (a process called sarcopenia) unless actively working to maintain it. Less muscle means fewer calories burned at rest. Less muscle also means less glucose gets absorbed from the bloodstream, which contributes directly to insulin resistance over time.

The Hormone Factor
Estrogen plays a larger metabolic role than most people realize. It improves insulin sensitivity, supports thyroid function, influences where the body stores fat (hips vs. abdomen), and regulates appetite signals. As estrogen begins its perimenopausal decline, the body increasingly shifts toward abdominal fat storage, reduces its response to insulin, and becomes more prone to inflammation — all of which make weight loss significantly more difficult through caloric restriction alone.
Cortisol compounds this. Chronic life stress, poor sleep, and even over-exercising all raise cortisol, which signals the body to hold onto fat stores — particularly around the midsection — as a survival mechanism.
What the Research Actually Supports
The evidence increasingly points toward a few core truths for women over 35: resistance training preserves the metabolic engine (muscle mass), protein intake matters more than total calorie restriction, and hormonal optimization — whether through lifestyle, HRT, or metabolic medications — is often necessary to unlock the metabolic response that calorie cutting alone cannot achieve.
GLP-1 receptor agonists like semaglutide and tirzepatide have emerged as genuinely transformative tools in this space, not because they suppress appetite by brute force, but because they restore the hormonal signaling around hunger and satiety that has become dysregulated in so many women.

A Different Approach Entirely
At Nuu Metabolic in Illinois, we start by understanding your individual metabolic picture before recommending any intervention. Labs that most practices don’t run — fasting insulin, comprehensive thyroid panels, sex hormone profiles, inflammatory markers — give us a map of what’s actually driving your symptoms. Treatment is then built around that picture, not a generic protocol.
Weight loss that sticks after 35 is not about trying harder. It’s about working with the biology you have right now — not the one you had at 25.
— Urooj Mujtaba, PA-C | Nuu Metabolic, Illinois